Beijing Qingke Biotechnology
A gene synthesis platform enterprise with an independent whole industry chain.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD340—510m (Dealroom.co estimates Dec 2022.)
Beijing China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY400m | Series B | |
| Total Funding | AUD85.0m | ||